Mietens syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2557OMIM:249600Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mietens syndrome (also known as Mietens-Weber syndrome) is an extremely rare autosomal recessive disorder characterized by a combination of ocular, skeletal, and neurological abnormalities. The condition was first described by Mietens and Weber in 1966 in a group of affected siblings. Key clinical features include corneal opacities (clouding of the cornea), strabismus (misaligned eyes), nystagmus (involuntary eye movements), short stature, flexion contractures of the elbows with dislocation of the radial head, and intellectual disability of variable severity. The skeletal abnormalities particularly affect the upper limbs, with limited extension at the elbows being a hallmark finding. Affected individuals may also exhibit a small nose with a narrow nasal bridge, contributing to a characteristic facial appearance. The syndrome affects multiple body systems, primarily the eyes, the musculoskeletal system, and the central nervous system. Growth retardation is typically present from early life, and the degree of intellectual disability can range from mild to moderate. The corneal abnormalities may significantly impair vision and can be present from birth or early infancy. There is currently no cure for Mietens syndrome, and management is supportive and symptomatic. Treatment may include ophthalmological interventions for corneal opacities and visual impairment, orthopedic management for skeletal contractures, and educational support for developmental delays. The molecular genetic basis of Mietens syndrome has not been fully elucidated, and the responsible gene has not been definitively identified. Given the extreme rarity of this condition, only a small number of cases have been reported in the medical literature.

Also known as:

Clinical phenotype terms— hover any for plain English:

EcholaliaHP:0010529Elbow ankylosisHP:0003070
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Mietens syndrome.

View clinical trials →

No actively recruiting trials found for Mietens syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mietens syndrome community →

No specialists are currently listed for Mietens syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mietens syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mietens syndromeForum →

No community posts yet. Be the first to share your experience with Mietens syndrome.

Start the conversation →

Latest news about Mietens syndrome

No recent news articles for Mietens syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Mietens syndrome

What is Mietens syndrome?

Mietens syndrome (also known as Mietens-Weber syndrome) is an extremely rare autosomal recessive disorder characterized by a combination of ocular, skeletal, and neurological abnormalities. The condition was first described by Mietens and Weber in 1966 in a group of affected siblings. Key clinical features include corneal opacities (clouding of the cornea), strabismus (misaligned eyes), nystagmus (involuntary eye movements), short stature, flexion contractures of the elbows with dislocation of the radial head, and intellectual disability of variable severity. The skeletal abnormalities particu

How is Mietens syndrome inherited?

Mietens syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Mietens syndrome typically begin?

Typical onset of Mietens syndrome is neonatal. Age of onset can vary across affected individuals.